US Broker Ratings

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Gem with 279% Potential Upside

LENZ Therapeutics, Inc. (NASDAQ: LENZ) has captured the attention of investors with its promising focus on improving vision through innovative therapies. Situated in the dynamic biotechnology sector, LENZ is headquartered..

STAAR Surgical (STAA) Stock Report: Navigating a 11.84% Potential Upside Amidst Volatile Metrics

STAAR Surgical Company (NASDAQ: STAA), a notable player in the medical instruments and supplies industry, is capturing investor attention with a potential upside of 11.84%. Based in Lake Forest, California,..

Zymeworks Inc. (ZYME) Stock Analysis: A High Upside Prospect with Promising Biotech Innovations

Zymeworks Inc. (NASDAQ: ZYME) is gaining attention in the biotech sector with a market cap of $1.81 billion. The company, which is headquartered in Middletown, Delaware, is a clinical-stage biotechnology..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Evaluating a Potential 46.86% Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a prominent player in the biotechnology sector, has recently caught the attention of investors with a notable potential upside of 46.86%. As a biopharmaceutical company..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 38.57% Upside Potential

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically in medical devices, is drawing investor attention with its compelling growth potential. Headquartered in Lewisville, Texas, Orthofix..

CureVac N.V. (CVAC) Investor Outlook: Analyzing the Biotech’s Future Amid Major Acquisition

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has recently attracted significant attention due to its acquisition by BioNTech SE. With a market capitalization of $1.05 billion,..

Immatics N.V. (IMTX) Stock Analysis: Potential 91% Upside Amid Strong Buy Ratings

Immatics N.V. (NASDAQ: IMTX), a biotechnology frontrunner in the healthcare sector, is capturing investor attention with its ambitious pipeline of cancer immunotherapies. Headquartered in Tübingen, Germany, the company is at..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS) is a player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $672.61 million, this US-based company is..

Nurix Therapeutics, Inc. (NRIX): Biotechnology Innovator with 86% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing attention in the biotechnology sector, primarily due to its promising drug development pipeline and a potential upside of 86.22%, as indicated by current..

Cronos Group Inc. (CRON): Investor Outlook on a Cannabis Pioneer with 47% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON) is a name that resonates with many investors interested in the burgeoning cannabis market. As a key player in the healthcare sector, specifically within the..

Butterfly Network, Inc. (BFLY) Stock Analysis: Innovative Medical Devices with a Potential 8.40% Upside

For investors seeking to tap into the burgeoning medical devices sector, Butterfly Network, Inc. (NYSE: BFLY) presents an intriguing opportunity. With its market cap sitting at $1.18 billion, this healthcare..

Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors

Embecta Corp. (EMBC), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry. The company is renowned for its diabetes care solutions, including pen needles, syringes,..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Uncovering a Potential 148% Upside in the Biotech Sector

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has been turning heads in the biotechnology sector with its focus on rare diseases and promising product pipeline. With a market capitalization of $511.74 million,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Potential 233% Upside in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company, is capturing investor attention with its substantial potential upside of 233.33%, making it a noteworthy candidate for those interested in the healthcare..

HealthStream, Inc. (HSTM) Stock Report: Exploring a 42.99% Potential Upside

HealthStream, Inc. (HSTM), a key player in the healthcare sector specializing in health information services, offers a compelling investment opportunity with an estimated potential upside of 42.99%. As of the..

Stoke Therapeutics (STOK) Investor Outlook: A Promising Biotech with 17.3% Upside Potential

Stoke Therapeutics, Inc. (STOK), a burgeoning name in the biotechnology sector, is captivating investor interest with its promising pipeline of genetic treatments and a notable potential upside of 17.3%. The..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking the 82% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a frontrunner in the biotechnology sector, is making waves with its ambitious aim to revolutionize treatment methodologies for diseases with unmet medical needs, particularly Duchenne..

RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector

RxSight, Inc. (RXST), a promising player in the medical technology arena, presents a unique opportunity for investors seeking exposure to the healthcare sector, specifically in the innovative medical devices space...

CareDx, Inc. (CDNA) Stock Analysis: 27.52% Potential Upside in the Healthcare Diagnostics Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare diagnostics and research sector, has caught the eye of investors with its robust growth prospects and a noteworthy potential upside of..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating the -24.73% Potential Downside Amid Healthcare Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specializes in providing comprehensive medical and ancillary services tailored for seniors, ensuring they can live independently while receiving..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds